ARK Investment Management LLC - Mar 31, 2025 SCHEDULE 13G/A Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager
ARK Investment Management LLC
Reporting Manager
ARK Investment Management LLC
Security
CRISPR Therapeutics AG Common Stock
Symbol
CRSP
Shares outstanding
85.8M shares
Disclosed Ownership
10.2M shares
Ownership
11.9%
Form type
SCHEDULE 13G/A
Date filed
5/14/2025, 10:52 AM
Date of event
Mar 31, 2025
Previous filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARK Investment Management LLC 11.85% 10.2M 9.55M 221K /s/ Kellen Carter Kellen Carter, Chief Compliance Officer
Catherine D. Wood 11.85% 10.2M 0 9.77M /s/ Catherine D. Wood Catherine D. Wood, Chief Executive Officer, Chief Investment Officer